Author:
Kondrashina Alina,Heffernan Shauna,O’Brien Nora,Giblin Linda
Reference167 articles.
1. Mechanisms underlying current and future anti-obesity drugs;Adan;Trends in Neurosciences,2013
2. Behavior of three hypocholesterolemic peptides from soy protein in an intestinal model based on differentiated Caco-2 cell;Aiello;Journal of Functional Foods,2018
3. MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: A randomised, controlled, double-blind, ascending dose and phase 2a study;Ambery;The Lancet,2018
4. Lacto-ghrestatin, a novel bovine milk-derived peptide, suppresses ghrelin secretion;Aoki;FEBS Letters,2017
5. Pharmacokinetics, safety, and tolerability of oral semaglutide in subjects with hepatic impairment;Bækdal;The Journal of Clinical Pharmacology,2018